Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments

Bibliographic Details
Main Authors: Xueyan Wang, Xiaowei Liu, Willy Hugo, Lu Si, Hubing Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1065937/full
_version_ 1797989757976838144
author Xueyan Wang
Xiaowei Liu
Willy Hugo
Lu Si
Hubing Shi
author_facet Xueyan Wang
Xiaowei Liu
Willy Hugo
Lu Si
Hubing Shi
author_sort Xueyan Wang
collection DOAJ
first_indexed 2024-04-11T08:25:28Z
format Article
id doaj.art-47de284bcd5b48128ca88268c518f7d5
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T08:25:28Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-47de284bcd5b48128ca88268c518f7d52022-12-22T04:34:46ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.10659371065937Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regimentsXueyan Wang0Xiaowei Liu1Willy Hugo2Lu Si3Hubing Shi4Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaLaboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, ChinaDivision of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, United StatesKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, ChinaLaboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1065937/fullimmune checkpoint blockade (ICB)melanomaimmune checkpoint inhibitors (ICIs)biomarkerimmune-related adverse events (irAEs)combination therapy
spellingShingle Xueyan Wang
Xiaowei Liu
Willy Hugo
Lu Si
Hubing Shi
Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
Frontiers in Immunology
immune checkpoint blockade (ICB)
melanoma
immune checkpoint inhibitors (ICIs)
biomarker
immune-related adverse events (irAEs)
combination therapy
title Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
title_full Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
title_fullStr Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
title_full_unstemmed Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
title_short Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
title_sort editorial improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
topic immune checkpoint blockade (ICB)
melanoma
immune checkpoint inhibitors (ICIs)
biomarker
immune-related adverse events (irAEs)
combination therapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1065937/full
work_keys_str_mv AT xueyanwang editorialimprovementofmelanomaimmunecheckpointblockadetherapywithpotentialcombinatorialregiments
AT xiaoweiliu editorialimprovementofmelanomaimmunecheckpointblockadetherapywithpotentialcombinatorialregiments
AT willyhugo editorialimprovementofmelanomaimmunecheckpointblockadetherapywithpotentialcombinatorialregiments
AT lusi editorialimprovementofmelanomaimmunecheckpointblockadetherapywithpotentialcombinatorialregiments
AT hubingshi editorialimprovementofmelanomaimmunecheckpointblockadetherapywithpotentialcombinatorialregiments